Page last updated: 2024-10-30

mefenamic acid and Purpura, Thrombotic Thrombocytopenic

mefenamic acid has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research Excerpts

ExcerptRelevanceReference
"Mefenamic acid is a fenamate nonsteroidal anti-inflammatory (NSAI) drug, which is used for several years for pain management."1.51Central nervous system toxicity due to mefenamic acid. ( Çaylak, ST; Doğan, NÖ; Yılmaz, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doğan, NÖ1
Çaylak, ST1
Yılmaz, S1

Other Studies

1 other study available for mefenamic acid and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Central nervous system toxicity due to mefenamic acid.
    The American journal of emergency medicine, 2019, Volume: 37, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Emergency Service, Hospital; Female; Humans; Mefenam

2019